U-M hepatologist hails hepatitis B treatment trial results
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Oct-2026 15:16 ET (30-Oct-2026 19:16 GMT/UTC)
University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well clinical trials as “a major step toward a functional cure for hepatitis B virus infection," in an editorial published in the New England Journal of Medicine.
A recent study from The University of Texas at San Antonio reveals that low-cost training for frontline health workers can significantly reduce medical supply shortages, potentially saving thousands of lives in developing nations.
Metabolic regulation at the maternal-embryo interface is essential for successful embryo implantation, yet its dynamics in humans remain poorly understood because of ethical and technical constraints. Researchers established a physiologically relevant maternal-embryo interaction model by co-culturing human blastoids with 3D endometrial assembloids, enabling analysis of metabolic changes during the implantation window. The study provides a systematic view of metabolic dynamics at the human maternal-embryo interface, identifies lipid remodeling and arachidonic acid (ARA) metabolism as key regulators of maternal and embryonic responses during implantation, and offers a mechanistic basis for diagnosis and metabolic intervention strategies in implantation failure.